Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
|
|
Arno Therapeutics, Inc (ARNI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2016 |
8-K
| Quarterly results |
| 03/17/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/30/2013 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...|
Docs:
|
"Form of Series C Warrant issued October 29, 2013",
"Form of Series D/E Warrant issued October 29, 2013",
"Securities Purchase Agreement dated October 29, 2013, among the Company and the Purchasers named therein",
"Registration Rights Agreement dated October 29, 2013, among the Company and the Holders identified therein",
"Conversion Agreement dated October 29, 2013, among the Company and the Holders of the Company’ s 2012 8% Senior Convertible Debentures",
"Amendment No. 2 dated October 29, 2013, to Securities Purchase Agreement and Registration Rights Agreement, each dated November 26, 2012, among the Company and the Purchasers identified therein",
"Agreement dated October 29, 2013, between the Company, OPKO Health, Inc. and Frost Group, LLC",
"Arno Therapeutics Completes $30.7 Million Financing, Recapitalization and 1-for-8 Reverse Stock Split" |
|
| 10/11/2013 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/18/2013 |
8-K
| Changes in Control of Registrant, Financial Statements and Exhibits |
| 01/14/2013 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 12/19/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 11/27/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...|
Docs:
|
"Certificate of Amendment of Amended & Restated Certificate of Incorporation of Arno Therapeutics, Inc",
"Form of 8% Senior Convertible Debenture due November 26, 2015",
"Form of Series A/B Warrant issued November 26, 2012",
"Securities Purchase Agreement among the Company and the Purchasers named therein",
"Registration Rights Agreement dated November 26, 2012, among the Company and the Holders identified therein",
"Press release of Arno Therapeutics, Inc." |
|
| 02/17/2012 |
8-K
| Form 8-K - Current report |
| 01/10/2012 |
8-K
| Form 8-K - Current report |
| 06/28/2011 |
8-K
| Form 8-K - Current report |
| 04/28/2011 |
8-K
| Form 8-K - Current report |
| 02/27/2009 |
8-K
| Form 8-K - Current report |
| 10/30/2008 |
8-K
| Form 8-K -- Current report |
| 09/03/2008 |
8-K
| Form 8-K -- Current report |
| 06/09/2008 |
8-K
| Appointed a new director|
Docs:
|
"Specimen Common Stock Certificate",
"Form of Arno Therapeutics, Inc. Common Stock Purchase Warrant",
"Employment Agreement between Arno Therapeutics, Inc. and Scott Z. Fields, M.D.",
"Letter agreement between Arno Therapeutics, Inc. and J. Chris Houchins",
"Arno Therapeutics, Inc. 2005 Stock Option Plan",
"Form of option agreement for use under 2005 Stock Option Plan",
"License Agreement between The University of Pittsburgh and Arno Therapeutics, Inc., dated October 25, 2006.+",
"License Agreement between Arno Therapeutics, Inc. and The Ohio State University Research Foundation, dated January 3, 2008.+",
"License Agreement between Arno Therapeutics, Inc. and The Ohio State University Research Foundation, dated January 9, 2008.+",
"Form of Subscription Agreement between Arno Therapeutics, Inc. and the investors in the June 2, 2008 private placement",
"Letter from Chang G. Park, CPA dated June 5, 2008, regarding change in certifying accountants",
"Forward-Looking Statements:",
"Unaudited financial statements of Arno Therapeutics, Inc. as of and for the three months ended March 31, 2008 and 2007 (pro forma financial information is not included, as the pro-forma information would not be materially different from Arno’s historical financial statements)",
"Audited financial statements of Arno Therapeutics, Inc. as of and for the year ended December 31, 2007 (pro forma financial information is not included, as the pro-forma information would not be materially different from Arno’s historical financial statements)" |
|
| 03/06/2008 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 10/01/2007 |
8-K
| Entry into a Material Definitive Agreement, Changes in Control of Registrant, Departure of Directors or Principal Officers; E... |
| 08/24/2006 |
8-K/A
| Changes in Registrant.s Certifying Accountant, Financial Statements and Exhibits |
| 08/04/2006 |
8-K
| Changes in Registrant.s Certifying Accountant, Financial Statements and Exhibits |
|
|